Valuation: Novartis AG

Market Cap 289B 251B 235B 214B 404B 27,625B 410B 2,769B 1,081B 13,828B 1,087B 1,063B 46,130B P/E 2026 *
21.6x
P/E 2027 * 18.5x
Enterprise Value 323B 280B 262B 239B 450B 30,785B 457B 3,086B 1,205B 15,410B 1,211B 1,185B 51,407B EV / Sales 2026 *
5.6x
EV / Sales 2027 * 5.19x
Free-Float
91.66%
Yield 2026 *
2.87%
Yield 2027 * 2.99%
1 day-1.83%
1 week-3.37%
Current month-3.84%
1 month-0.56%
3 months+4.34%
6 months-3.73%
Current year+11.08%
1 week 121.02
Extreme 121.02
127.66
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-1.87%-3.37%+23.51%+33.90% 289B
-2.62%-0.43%+72.50%+119.44% 1,078B
-0.95%+0.68%+49.38%+50.48% 632B
-1.12%+1.31%+21.78%+63.70% 443B
-2.25%-3.59%+41.58%+33.70% 356B
-2.50%-3.51%-0.93%+3.28% 245B
-1.44%+0.81%+42.71%+58.75% 226B
-1.29%-2.85%-8.66%-52.14% 204B
-0.81%+3.34%+15.67%+72.40% 171B
-0.76%-0.39%+6.15%-26.10% 153B
Average -1.53%+1.48%+26.37%+35.74% 379.64B
Weighted average by Cap. -1.76%+1.33%+40.00%+58.61%

Financials

2026 *2027 *
Net sales 57.58B 49.91B 46.79B 42.66B 80.28B 5,496B 81.56B 551B 215B 2,751B 216B 212B 9,177B 61.12B 52.98B 49.67B 45.29B 85.21B 5,834B 86.57B 585B 228B 2,920B 229B 225B 9,741B
Net income 13.78B 11.94B 11.2B 10.21B 19.21B 1,315B 19.52B 132B 51.47B 658B 51.74B 50.62B 2,196B 15.36B 13.31B 12.48B 11.38B 21.41B 1,466B 21.75B 147B 57.36B 734B 57.66B 56.41B 2,448B
Net Debt 33.11B 28.7B 26.91B 24.53B 46.16B 3,160B 46.9B 317B 124B 1,582B 124B 122B 5,277B 27.82B 24.11B 22.6B 20.61B 38.78B 2,655B 39.4B 266B 104B 1,329B 104B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
14/08/26 CHF 121.78 -1.58% 881,559
13/08/26 CHF 123.74 -0.37% 1,625,128
12/08/26 CHF 124.20 -1.32% 2,069,949
11/08/26 CHF 125.86 -0.74% 1,913,995
10/08/26 CHF 126.80 +0.65% 1,791,666
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
152.28USD
Average target price
154.18USD
Spread / Average Target
+1.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock